Author

Lisa L.R. Hartman

Observed names: L Hartman, L. Hartman, Lisa LR Hartman, Lisa L.R. Hartman

Institution: Mayo Clinic

Observed institutions: Texas Tech University, Children's Hospital of Orange County, Mayo Clinic, Emory University, Lund University, Sahlgrenska University Hospital, University of California San Diego, El Paso Children's Hospital, Children's Healthcare of Atlanta, Moores Cancer Center, University of Gothenburg, Texas Tech University Health Sciences Center

OpenAlex ID: A5110184631

Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors

2013 · Lisa L.R. Hartman, John R. Crawford, et al. · Journal of Pediatric Hematology/Oncology · 45

Integration of a Personalized Molecular Targeted Therapy into the Multimodal Treatment of Refractory Childhood Embryonal Tumor with Multilayered Rosettes (ETMR)

2019 · Lisa L.R. Hartman, Derrick M. Oaxaca, et al. · Case Reports in Oncology · 9

A-373 Comparison of the CoaguChek ® and Coag-Sense ® PT2 Meter Point of Care INR Devices

2023 · T Schumann, B Karon, et al. · Clinical Chemistry · 1

Ps1584 a Phase Ii Dose‐finding Study of Dalteparin in Children With Vte With or Without Cancer

2019 · L. Hartman, I. Nurmeev, et al. · HemaSphere · 1

Abstract P1-09-03: Relative radioresistency in triple negative tumors in the SweBCG91-RT randomized clinical trial

2017 · M Sjöström, D Lundstedt, et al. · Cancer Research

Abstract B73: Integration of a personalized molecular targeted therapy into the multimodal treatment of refractory early childhood sPNET

2014 · Lisa LR Hartman, Diba Farah, et al. · Cancer Research

Works count: 6

Citation count: 56

H-index: 2

I10-index: 1